期刊文献+

移植物抗宿主病对白血病异基因外周血干细胞移植预后的影响 被引量:9

Impact of graft versus host disease on outcome of allogeneic peripherial blood stem cell transplantation for leukemia
原文传递
导出
摘要 目的 探讨异基因外周血干细胞移植(allo-PBSCT)后急性移植物抗宿主病(aGVHD)和慢性GVHD (cGVHD)的严重程度对白血病患者预后的影响及发生的相关危险因素.方法 回顾性分析2001年1月1日至2011年12月31日接受allo-PBSCT的231例白血病患者的临床资料.分析aGVHD、cGVHD的发生率及其对患者移植后总生存(OS)率、无病生存(DFS)率、移植相关死亡(TRM)率和复发率(RR)的影响.结果 ①可评估的224例患者中85例发生aGVHD,其中Ⅰ度46例,Ⅱ度25例,Ⅲ~Ⅳ度14例.生存100 d以上者213例,109例发生cGVHD,其中局限型84例,广泛型25例.②0~Ⅰ度aGVHD患者3年OS和DFS率高于Ⅱ~Ⅳ度aGVHD患者(分别为69.5%和60.7%对33.6%和33.7%,P值均<0.01);前者3年TRM率低于后者(15.0%对56.7%,P<0.01).③局限型cGVHD患者5年OS率高于无cGVHD及广泛型cGVHD患者(79.8%对55.6%,P<0.01;79.8%对56.4%,P=0.038);局限型cGVHD患者5年TRM率低于广泛型cGVHD患者(14.1%对41.1%,P=0.018);无cGVHD患者5年RR不仅高于局限型cGVHD患者(47.2%对10.9%,P<0.01),也高于广泛型cGVHD患者(47.2%对12.4%,P=0.007).④多因素分析提示供者类型、清髓性预处理是allo-PBSCT后发生aGVHD的主要危险因素;而aGVHD又是发生cGVHD的唯一危险因素.结论 aGVHD对白血病患者allo-PBSCT后长期生存有明显不良影响,尤其是Ⅲ~Ⅳ度aGVHD对患者的影响更加显著;而局限型cGVHD则是患者长期生存的有益因素,可能与之伴随的移植物抗白血病效应降低白血病复发相关. Objective To analyze the impact of the occurrence and severity of acute and chronic graft versus host disease (GVHD) on the long-term outcome of allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for leukemia. Methods A total of 231 patients with leukemia, who underwent allo-HSCT in Changhai Hospital from Jan 1st, 2001 to Dec 31th, 2011, were retrospectively analyzed. The overall survival (OS), disease-free survival (DFS), transplantation-related mortality (TRM) and relapse rate (RR) were estimated according to the degree of acute and chronic GVHD. Results (1) Among the 224 assessable patients, aGVHD was observed in 85 patients, in which 46 developed grade Ⅰ, 25 grade Ⅱ and 14 grade Ⅲ -Ⅳ. A total of 213 patients who survived beyond 100 days, cGVHD was observed in 109 patients, in which 84 developed limited cGVHD and 25 extensive cGVHD. (2)The incidence of 3-year OS and EFS of patients with aGVHD grade 0- Ⅰ was significantly higher than that of grade Ⅱ -Ⅳ (69.5% vs 33.6%, P〈0.01; 60.7% vs 33.7%, P〈0.01 ). The 3-year TRM of patients with 0- Ⅰ grade aGVHD was significantly lower than that of the grade Ⅱ -Ⅳ group ( 15.0% vs56.7%, P〈0.01 ). (3)The 5-year OS of patients with limited cGVHD was higher than patients without or with extensive cGVHD (79.8% vs 55.6% and 56.4%, P〈0.0I and P=0.038, respectively). The 5-year TRM in patients with extensive cGVHD was higher than patients with limited cGVHD (14.1% vs 41.1%, P=- 0.018). However, the 5- year RR in patients without cGVHD was higher than patients with limited cGVHD or extensive cGVHD (47.2% vs 10.9% and 12.4%, P〈0.01 and P=0.007, respectively). (4) The COX analysis showed that unrelated donor and myeloablative conditioning regimen were main factors affecting aGVHD; Meanwhile, aGVHD was the only factor affecting the cGVHD. Conclusion Our results showed that the patients with acute GVHD tended to have poor outcomes, especially with grade Ⅲ-Ⅳ. On the contrary,
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第5期428-433,共6页 Chinese Journal of Hematology
基金 国家自然科学基金(81270639) 长海医院“1255”计划(CH125521000)
关键词 白血病 外周血干细胞移植 移植物抗宿主病 预后 Leukemia Peripheral blood stem cell transplantation Graft versus host disease Prognosis
  • 相关文献

参考文献12

  • 1Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment [J]. Stem Cells Transl Med, 2013, 2( 1 ):25-32. 被引量:1
  • 2Rafeah NT, Fadilah SA. The A-B-C of haematopoietic stem cell transplantation[J]. Med J Malaysia, 2009, 64 (1):94-100; quiz 101. 被引量:1
  • 3Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading [J]. Bone Marrow Transplant,1995,15 (6) :825-828. 被引量:1
  • 4Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors [J]. Transplantation, 1974,18 (4): 295-304. 被引量:1
  • 5Saber W, Opie S, Rizzo JD, et al. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia [J]. Blood, 2012, 119(17): 3908-3916. 被引量:1
  • 6Wojnar J, Giebel S, Krawczyk-Kulis M, et al. Acute graft-versus- host disease. The incidence and risk factors [J]. Ann Transplant, 2006,11 ( 1 ): 16-23. 被引量:1
  • 7陈育红,黄晓军,郭乃榄,任汉云,张耀臣,许兰平,高志勇,陆道培.异基因造血干细胞移植后急性移植物抗宿主病的发生及其危险因素的探讨[J].中华血液学杂志,2003,24(2):61-63. 被引量:45
  • 8Baron F, Labopin M, Niederwieser D, et al. Impact of graft- versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation [J]. Leukemia, 2012, 26 ( 12 ) :2462-2468. 被引量:1
  • 9Ringden O, Labopin M, Beelen DW, et al. Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients [J]. J Intern Med, 2012, 272(5):472-483. 被引量:1
  • 10Ozawa S, Nakaseko C, Nishimura M, et al. Chronic graft-versus- host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program[J]. Br J Haematol, 2007, 137(2):142-151. 被引量:1

二级参考文献12

共引文献51

同被引文献111

  • 1陈瑶,陆道培,刘开彦,董陆佳,任汉云,黄晓军,陈欢,刘代红,江倩,陈育红,许兰平,张耀臣,路瑾,高志勇.异基因造血干细胞移植后急性移植物抗宿主病151例危险因素分析[J].中华血液学杂志,2005,26(2):74-77. 被引量:29
  • 2郭霞,李强.急性白血病发病机制研究进展[J].实用儿科临床杂志,2005,20(7):690-693. 被引量:17
  • 3夏凌辉,邹萍,胡俊斌,游泳,方峻,郭涛,刘芳,张纯,崔国惠,谢薇,宋善俊.异基因造血干细胞移植后慢性移植物抗宿主病的临床分析[J].中华器官移植杂志,2007,28(7):428-432. 被引量:8
  • 4陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919. 被引量:692
  • 5Bethge WA, Faul C, Bornh:iuser M, et al. Haploidentical alloge- neic hematopoietic cell transplantation in adults using CD3/ CD19 depletion and reduced intensity conditioning: an update [ J ]. Blood Cells Mol Dis, 2008,40 ( 1 ): 13-19. 被引量:1
  • 6Huang X J, Liu DH, Liu KY, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies [J]. Bone Marrow Transplant, 2006, 38(4) :291-297. 被引量:1
  • 7Lu DP, Dong L,Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploi- dentical blood and marrow transplantation can achieve compara- ble outcomes with HLA-identical sibling transplantation [Jl. Blood,2006,107 ( 8 ) :3065-3073. 被引量:1
  • 8Thomas ED, Storb R, Clift RA, et al. Bone marrow transplanta- tion[J]. N Eng J Med[J], 1975, 292( 17):895-902. 被引量:1
  • 9Hansen JA, Petersdorf E, Martin P J, et al. Hematopoietic stem cell transplants from unrelated donors [J]. Immunol Rev, 1997, 157:141-151. 被引量:1
  • 10Powles RL,Morgenstem GR,Kay HE,et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukemia [ J ]. Lancet, 1983,1 ( 8325 ) : 612-615. 被引量:1

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部